Citations (20)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Ulla Bregendahl Nielsen, Laerke Valsøe Bruhn, Torkell Ellingsen, Kristian Stengaard-Pedersen & Nete Hornung. (2018) Calprotectin in patients with chronic rheumatoid arthritis correlates with disease activity and responsiveness to methotrexate. Scandinavian Journal of Clinical and Laboratory Investigation 78:1-2, pages 62-67.
Read now
Read now
Natalie E Walsham & Roy A Sherwood. (2016) Fecal calprotectin in inflammatory bowel disease. Clinical and Experimental Gastroenterology 9, pages 21-29.
Read now
Read now
Articles from other publishers (18)
Anne Grosen, Mona Bungum, Lisbet Ambrosius Christensen, Eugenia Cordelli, Ole Halfdan Larsen, Giorgio Leter, Mette Julsgaard, Thea Vestergaard, Paola Villani, Christian Lodberg Hvas & Jens Kelsen. (2019) Semen Quality and Sperm DNA Integrity in Patients With Severe Active Inflammatory Bowel Disease and Effects of Tumour Necrosis Factor-alpha Inhibitors. Journal of Crohn's and Colitis 13:5, pages 564-571.
Crossref
Crossref
Juan Egea Valenzuela, Gonzalo Antón Ródenas & Ana Sánchez Martínez. (2019) Marcadores de actividad en la enfermedad inflamatoria intestinal. Medicina Clínica 152:8, pages 310-316.
Crossref
Crossref
Juan Egea Valenzuela, Gonzalo Antón Ródenas & Ana Sánchez Martínez. (2019) Use of biomarkers in inflammatory bowel disease. Medicina Clínica (English Edition) 152:8, pages 310-316.
Crossref
Crossref
Dae Gon Ryu, Hyung Wook Kim, Su Bum Park, Dae Hwan Kang, Cheol Woong Choi, Su Jin Kim & Hyeong Seok Nam. (2019) Clinical implications of fecal calprotectin and fecal immunochemical test on mucosal status in patients with ulcerative colitis. Medicine 98:36, pages e17080.
Crossref
Crossref
Catherine Reenaers, Peter Bossuyt, Pieter Hindryckx, Hilde Vanpoucke, Anneline Cremer & Filip Baert. (2018) Expert opinion for use of faecal calprotectin in diagnosis and monitoring of inflammatory bowel disease in daily clinical practice. United European Gastroenterology Journal 6:8, pages 1117-1125.
Crossref
Crossref
Takahiko Toyonaga, Taku Kobayashi, Masaru Nakano, Eiko Saito, Satoko Umeda, Shinji Okabayashi, Ryo Ozaki & Toshifumi Hibi. (2017) Usefulness of fecal calprotectin for the early prediction of short-term outcomes of remission-induction treatments in ulcerative colitis in comparison with two-item patient-reported outcome. PLOS ONE 12:9, pages e0185131.
Crossref
Crossref
Mette Julsgaard, Christian L. Hvas, Richard B. Gearry, Thea Vestergaard, Jan Fallingborg, Lise Svenningsen, Jens Kjeldsen, Miles P. Sparrow, Signe Wildt, Jens Kelsen & Sally J. Bell. (2017) Fecal Calprotectin Is Not Affected by Pregnancy. Inflammatory Bowel Diseases 23:7, pages 1240-1246.
Crossref
Crossref
Anna-Maija Puolanne, Kaija-Leena Kolho, Henrik Alfthan, Ari Ristimäki, Harri Mustonen & Martti Färkkilä. (2016) Rapid faecal tests for detecting disease activity in colonic inflammatory bowel disease. European Journal of Clinical Investigation 46:10, pages 825-832.
Crossref
Crossref
Marina Aloi, Giulia DʼArcangelo, Matteo Bramuzzo, Marco Gasparetto, Massimo Martinelli, Patrizia Alvisi, Maria Teresa Illiceto, Simona Valenti, Manuela Distante, Salvatore Pellegrino, Simona Gatti, Serena Arrigo, Fortunata Civitelli & Stefano Martelossi. (2016) Effect of Early Versus Late Azathioprine Therapy in Pediatric Ulcerative Colitis. Inflammatory Bowel Diseases 22:7, pages 1647-1654.
Crossref
Crossref
Christian L. Hvas, Anders Dige, Mia Bendix, Pernille G. Wernlund, Lisbet A. Christensen, Jens F. Dahlerup & Jørgen Agnholt. (2016) Casein glycomacropeptide for active distal ulcerative colitis: a randomized pilot study. European Journal of Clinical Investigation 46:6, pages 555-563.
Crossref
Crossref
Klaus Theede, Susanne Holck, Per Ibsen, Thomas Kallemose, Inge Nordgaard-Lassen & Anette Mertz Nielsen. (2016) Fecal Calprotectin Predicts Relapse and Histological Mucosal Healing in Ulcerative Colitis. Inflammatory Bowel Diseases 22:5, pages 1042-1048.
Crossref
Crossref
D. Seah & P. De Cruz. (2016) Review article: the practical management of acute severe ulcerative colitis. Alimentary Pharmacology & Therapeutics 43:4, pages 482-513.
Crossref
Crossref
Samuel Raimundo Fernandes, Patrícia Santos, Carlos Miguel Moura, Pedro Marques da Costa, Joana Rita Carvalho, Ana Isabel Valente, Cilénia Baldaia, Ana Rita Gonçalves, Paula Moura Santos, Luís Araújo-Correia & José Velosa. (2016) The use of a segmental endoscopic score may improve the prediction of clinical outcome in acute severe ulcerative colitis. Revista Española de Enfermedades Digestivas 108.
Crossref
Crossref
M. Isabel Ordiz, Thaddaeus D. May, Kathie Mihindukulasuriya, John Martin, Jan Crowley, Phillip I. Tarr, Kelsey Ryan, Elissa Mortimer, Geetha Gopalsamy, Ken Maleta, Makedonka Mitreva, Graeme Young & Mark J. Manary. (2015) The effect of dietary resistant starch type 2 on the microbiota and markers of gut inflammation in rural Malawi children. Microbiome 3:1.
Crossref
Crossref
Klaus Theede, Susanne Holck, Per Ibsen, Steen Ladelund, Inge Nordgaard-Lassen & Anette Mertz Nielsen. (2015) Level of Fecal Calprotectin Correlates With Endoscopic and Histologic Inflammation and Identifies Patients With Mucosal Healing in Ulcerative Colitis. Clinical Gastroenterology and Hepatology 13:11, pages 1929-1936.e1.
Crossref
Crossref
Laith Alrubaiy, Ibtihal Rikaby, Mohamed Sageer, Hayley Anne Hutchings & John Gordon Williams. (2015) Systematic Review of the Clinical Disease Severity Indices for Inflammatory Bowel Disease. Inflammatory Bowel Diseases, pages 1.
Crossref
Crossref
David L. Suskind. (2015) Author's Response. Journal of Pediatric Gastroenterology & Nutrition 60:4, pages e37.
Crossref
Crossref
Frank S. Lehmann, Emanuel Burri & Christoph Beglinger. (2014) The role and utility of faecal markers in inflammatory bowel disease. Therapeutic Advances in Gastroenterology 8:1, pages 23-36.
Crossref
Crossref